Literature DB >> 36267133

Boron-Containing Pyrazole Compounds as JAK Inhibitors for Treating Inflammation, Autoimmune Diseases, and Cancer.

Ram W Sabnis1.   

Abstract

Provided herein are novel boron-containing pyrazole compounds as JAK inhibitors, pharmaceutical compositions, use of such compounds in treating inflammation, autoimmune diseases, and cancer, and processes for preparing such compounds. Published 2022 by American Chemical Society.

Entities:  

Year:  2022        PMID： 36267133      PMCID： PMC9578537          DOI： 10.1021/acsmedchemlett.2c00407

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


  4 in total

Review 1.  Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders.

Authors:  Robert Roskoski
Journal:  Pharmacol Res       Date:  2022-07-22       Impact factor: 10.334

Review 2.  JAK inhibitors and systemic sclerosis: A systematic review of the literature.

Authors:  Clothilde Moriana; Thomas Moulinet; Roland Jaussaud; Paul Decker
Journal:  Autoimmun Rev       Date:  2022-08-06       Impact factor: 17.390

Review 3.  A literature review on Janus kinase (JAK) inhibitors for the treatment of immunobullous disorders.

Authors:  Yasamin Kalantari; Sara Sadeghi; Delaram Asadi; Azadeh Goodarzi
Journal:  Int Immunopharmacol       Date:  2022-06-16       Impact factor: 5.714

Review 4.  User's guide to JAK inhibitors in inflammatory bowel disease.

Authors:  Ted A Spiewak; Anish Patel
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.